• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺原发性神经内分泌癌:一种罕见的表现及文献综述

Primary neuroendocrine carcinoma of the breast: a rare presentation and review of the literature.

作者信息

Salemis Nikolaos S

机构信息

Breast Cancer Surgery Unit, Army General Hospital, Athens, Greece.

IASO Women's Hospital, Athens, Greece.

出版信息

Intractable Rare Dis Res. 2020 Nov;9(4):233-246. doi: 10.5582/irdr.2020.03046.

DOI:10.5582/irdr.2020.03046
PMID:33139983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7586876/
Abstract

Primary neuroendocrine carcinoma of the breast (NEBC) is a very rare occurrence accounting for less than 0.1% of all breast cancers. Typically, the tumor presents with ER- and PgR-positive and HER-2-negative status. Despite its luminal type, NEBC is associated with a more aggressive clinical course and poorer prognosis compared to the other types of invasive breast cancer. Clinical and radiological findings are nonspecific. The most common clinical manifestation is a palpable mass whereas in mammography the tumor most commonly appears as a round or oval mass without spiculated margins. Herein, a very rare case of NEBC is described in an asymptomatic patient who presented with an area of architectural distortion and the presence of microcalcifications that was incidentally detected on a screening mammography. A review of the literature has also been conducted. The diagnosis of NEBC requires a thorough investigation to exclude the possibility of a metastatic neuroendocrine tumor from another site because the two entities require different treatment approaches. Due to the rarity of the disease, the optimal therapeutic approach has not been clearly defined. Surgical resection is the mainstay of treatment. Further research is needed to better understand the molecular characteristics of NEBC and identify novel targeted therapies.

摘要

乳腺原发性神经内分泌癌(NEBC)极为罕见,占所有乳腺癌的比例不到0.1%。通常,该肿瘤表现为雌激素受体(ER)和孕激素受体(PgR)阳性、人表皮生长因子受体2(HER-2)阴性。尽管NEBC属于管腔型,但与其他类型的浸润性乳腺癌相比,其临床病程更具侵袭性,预后更差。临床和影像学表现不具有特异性。最常见的临床表现是可触及的肿块,而在乳腺钼靶检查中,肿瘤最常表现为圆形或椭圆形肿块,边缘无毛刺。本文描述了一例非常罕见的NEBC病例,患者无症状,在筛查乳腺钼靶检查时偶然发现有结构扭曲区域并伴有微钙化。同时也对相关文献进行了综述。NEBC的诊断需要进行全面检查,以排除其他部位转移性神经内分泌肿瘤的可能性,因为这两种实体需要不同的治疗方法。由于该疾病罕见,最佳治疗方法尚未明确界定。手术切除是主要治疗手段。需要进一步研究以更好地了解NEBC的分子特征并确定新的靶向治疗方法。

相似文献

1
Primary neuroendocrine carcinoma of the breast: a rare presentation and review of the literature.乳腺原发性神经内分泌癌:一种罕见的表现及文献综述
Intractable Rare Dis Res. 2020 Nov;9(4):233-246. doi: 10.5582/irdr.2020.03046.
2
Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review.神经内分泌分化型乳腺癌病例:一项回顾性分析及文献综述
Sisli Etfal Hastan Tıp Bul. 2021 Dec 29;55(4):503-509. doi: 10.14744/SEMB.2021.66503. eCollection 2021.
3
Primary neuroendocrine carcinomas of the breast and neuroendocrine differentiated breast cancers: Relationship between histopathological and radiological features.乳腺原发性神经内分泌癌和神经内分泌分化型乳腺癌:组织病理学和影像学特征的关系。
Eur J Radiol. 2022 Feb;147:110148. doi: 10.1016/j.ejrad.2021.110148. Epub 2022 Jan 4.
4
Routine Screening Mammogram Leading to the Incidental Diagnosis of a Metastatic Neuroendocrine Breast Cancer (NEBC) from an Unrecognized Asymptomatic Small Bowel Neuroendocrine Tumor.常规筛查乳腺钼靶检查意外诊断出一例源于未被识别的无症状小肠神经内分泌肿瘤的转移性神经内分泌乳腺癌(NEBC)。
Cureus. 2022 Mar 18;14(3):e23302. doi: 10.7759/cureus.23302. eCollection 2022 Mar.
5
Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.实性神经内分泌乳腺癌:发病率、临床病理特征及免疫组化分析
Oncol Rep. 2008 Dec;20(6):1369-74.
6
Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study.原发性神经内分泌乳腺癌尽管生物学特征良好,但局部控制不良:一项回顾性临床研究。
BMC Cancer. 2017 Jan 24;17(1):72. doi: 10.1186/s12885-017-3056-4.
7
Neuroendocrine breast carcinoma: a rare but challenging entity.神经内分泌乳腺癌:一种罕见但极具挑战性的实体。
Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
8
Neuroendocrine Cancer of the Breast: A Rare Entity.乳腺神经内分泌癌:一种罕见的实体瘤。
J Clin Med. 2020 May 13;9(5):1452. doi: 10.3390/jcm9051452.
9
Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature.神经内分泌性乳腺癌(NEBC)的管理:文献综述
Oncol Rev. 2024 Feb 9;18:12114. doi: 10.3389/or.2024.12114. eCollection 2024.
10
Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.具有神经内分泌特征的原发性乳腺癌与模拟神经内分泌特征的原发性乳腺癌之间的组织病理学和临床差异
Int J Surg Pathol. 2019 Oct;27(7):744-752. doi: 10.1177/1066896919851873. Epub 2019 Jun 14.

引用本文的文献

1
Primary neuroendocrine tumor of the breast: A case report.乳腺原发性神经内分泌肿瘤:一例报告。
Oncol Lett. 2024 Nov 27;29(2):79. doi: 10.3892/ol.2024.14825. eCollection 2025 Feb.
2
CDK4/6 and aromatase inhibitors as first-line treatment in metastatic high-grade neuroendocrine carcinoma of the breast: A case report.CDK4/6抑制剂与芳香化酶抑制剂作为转移性高级别乳腺神经内分泌癌的一线治疗:一例报告
Clin Case Rep. 2024 Jul 16;12(7):e9180. doi: 10.1002/ccr3.9180. eCollection 2024 Jul.
3
Clinicopathological Characteristics and Prognostic Profiles of Breast Carcinoma with Neuroendocrine Features.具有神经内分泌特征的乳腺癌的临床病理特征及预后分析
Life (Basel). 2023 Feb 15;13(2):532. doi: 10.3390/life13020532.
4
Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types.病例报告:原发性神经内分泌乳腺癌病例的广泛肿瘤分析作为罕见侵袭性癌症类型个性化治疗的范例
Front Med (Lausanne). 2022 Jun 3;9:841441. doi: 10.3389/fmed.2022.841441. eCollection 2022.
5
Primary neuroendocrine carcinoma of the breast with paraneoplastic thrombocytosis; a rare case report.乳腺原发性神经内分泌癌伴副肿瘤性血小板增多症;1例罕见病例报告
Ann Med Surg (Lond). 2022 Apr 22;77:103664. doi: 10.1016/j.amsu.2022.103664. eCollection 2022 May.

本文引用的文献

1
Neuroendocrine carcinoma of the breast with hyperprolactinemia: report of two cases and a minireview.伴有高催乳素血症的乳腺神经内分泌癌:两例报告及文献综述
Int J Clin Exp Pathol. 2020 Jun 1;13(6):1457-1462. eCollection 2020.
2
A rare breast tumor: primary neuroendocrine carcinoma.一种罕见的乳腺肿瘤:原发性神经内分泌癌。
Turk J Surg. 2018 Jan 3;35(3):236-240. doi: 10.5152/UCD.2016.3109. eCollection 2019 Sep.
3
Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review.乳腺原发性神经内分泌肿瘤:病例系列与文献综述
Cancers (Basel). 2020 Mar 20;12(3):733. doi: 10.3390/cancers12030733.
4
Primary neuroendocrine carcinoma of the breast: a 5-year experiences.乳腺原发性神经内分泌癌:5 年经验。
Ann Ital Chir. 2020;91:23-26.
5
Primary neuroendocrine tumors of the breast: two case reports and review of the literature.乳腺原发性神经内分泌肿瘤:两例病例报告及文献综述
J Med Case Rep. 2020 Mar 10;14(1):41. doi: 10.1186/s13256-020-02361-5.
6
Primary neuroendocrine carcinoma of the breast: A case report of liver and lymph node metastases after eight years from diagnosis.乳腺原发性神经内分泌癌:诊断 8 年后肝及淋巴结转移 1 例报告。
Breast J. 2020 Mar;26(3):505-507. doi: 10.1111/tbj.13535. Epub 2019 Sep 12.
7
Primary neuroendocrine carcinoma of the breast.乳腺原发性神经内分泌癌
Breast J. 2019 May;25(3):519-520. doi: 10.1111/tbj.13260. Epub 2019 Apr 18.
8
Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.乳腺神经内分泌癌的潜在新型治疗靶点。
Clin Breast Cancer. 2019 Apr;19(2):131-136. doi: 10.1016/j.clbc.2018.09.001. Epub 2018 Sep 5.
9
Triple receptor-positive primary neuroendocrine carcinoma of breast in a young patient.一名年轻患者的三受体阳性原发性乳腺神经内分泌癌
BMJ Case Rep. 2018 Jan 4;2018:bcr-2017-223280. doi: 10.1136/bcr-2017-223280.
10
Neuroendocrine Tumors of the Breast.乳腺神经内分泌肿瘤
Arch Pathol Lab Med. 2017 Nov;141(11):1577-1581. doi: 10.5858/arpa.2016-0364-RS.